CAS: 51460-47-0; Thiophene-3-Carboxamide

该化合物是一种有机化合物,其特点是五人组成的含有硫磺的热循环芳香环.在硫苯环的三处放置时,一个碳白胺功能组(-C(=O)NH2)具有特定的化学特性,包括能够参与氨化物组的氢联结.该化合物一般在室温下是固体,可能由于碳白组的极地性质而在极地溶剂中表现出中等溶解性.Thiophene-3-carboxamide可以参与各种化学反应,包括核阴极替代和混合反应,从而引起对有机合成和材料科学的兴趣.其衍生物可能展示出生物活动,可以用于潜在的药物应用.该化合物的稳定性和再活性可能受到硫酰环子构成的影响,从而在合成化学中成为一个多用途建筑块.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

3-thiophene carboxylic acid chloride 3-thiophenecarbonitrile 3-Bromothiophene 3-thienyl iodide N-(thiophen-3-yl)acetamide N-Thiophen-3-yl-benzamide 5-nitrothiophene-3-carboxamide 4-methyl-N-(thiophen-3-yl)benzenesulfonamide

合成工艺路线路线简述

    📜3-甲基噻吩置于叔丁基过氧化氢,Iron(Iii) Chloride Hexahydrate,Tetrabutylammonium Iodide,Ammonium Hydroxide体系中,用 水 作为反应溶剂,化学反应 18.0H,以50%的收率获得产物3-噻吩甲酰胺
    参考文献:甲基芳烃与氨之间的氧化偶联:芳族伯酰胺的直接方法
    标题:甲基芳烃与氨之间的氧化偶联:芳族伯酰胺的直接方法
    摘要:已经开发了一种使用叔丁基氢过氧化物和四丁基碘化铵(tbhp / Tbai)氧化系统与氯化铁(iii)共同催化的甲基芳烃和氨水之间的直接氧化酰胺化方法.两种偶联伙伴均以其天然形式使用,以使之前的官能化变得不必要,并提供了一种简便的方法来制备芳族伯酰胺.
    DOI:10.1002/adsc.201500310

    海关参考信息

    专利信息


    专利号:US-7179918-B2
    优先权日:2001-06-11
    标 题:HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
    发明人:CANAN KOCH STACIE S; ALEXANDER THERESE N; BURKE BENJAMIN J; JEWELL TANYA M; KUCERA DAVID J; LINTON MARIA ANGELICA; MITCHELL JR LENNERT J; REICH SIEGFRIED H; SKALITZKY DONALD J; TATLOCK JOHN H; VARNEY MICHAEL D; VIRGIL SCOTT C; WEBBER STEPHEN E; WORLAND STEPHEN T; BARVIAN MARK; BOLTON GARY; BOYER JR FREDERICK EARL; MACHAK JEFFREY J; HOLLER TOD; MURPHY SEAN T; MELNICK MICHAEL; JOSYULA VARA PRASAD
    权利人:AGOURON PHARMA
    摘要:Compounds of the formula: n nwhere the formula variables are as defined herein, are disclosed that advantageously inhibit or block the biological activity of the HIV protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with the HIV virus. Intermediates and synthetic methods for preparing such compounds are also described.

    专利号:US-2007275962-A1
    优先权日:2003-09-10
    标 题:Heterobicyclic Compounds as Pharmaceutically Active Agents
    发明人:KOUL ANIL; KLEBL BERT; MULLER GERHARD; MISSIO ANDREA; SCHWAB WILFRIED; HAFENBRADL DORIS; NEUMANN LARS; SOMMER MARC-NICOLA; MULLER STEFAN; HOPPE EDMUND; FREISLEBEN ACHIM; BACKES ALEXANDER; HARTUNG CHRISTIAN; FELBER BEATRICE; ZECH BIRGIT; ENGKVIST OLA; KERI GYORGY; ORFI LASZLO; BANHEGYI PETER; GREFF ZOLTAN; HORVATH ZOLTAN; VARGA ZOLTAN; MARKO PETER; PATO JANOS; SZABADKAI ISTVAN; SZEKELYHID ZSOLT; WACZEK FRIGYES
    权利人:GPC BIOTECH AG
    摘要:Described are heterobicyclic compounds such as 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid amides, 4,7-dihydro-5H-thieno[2,3-c]thiopyran 3-carboxylic acid amides, 4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid amides, or benzo[b]thiophene-3-carboxylic acid amides and pharmaceutically acceptable salts thereof, the use of these derivatives for the prophylaxis and/or treatment of various diseases such as infectious diseases, including mycobacteriainduced infections and opportunistic diseases, prion diseases, immunological diseases, autoimmune diseases, bipolar and clinical disorders, cardiovascular diseases, cell proliferative diseases, diabetes, inflammation, transplant rejections, erectile dysfunction, neurodegenerative diseases and stroke, as well as compositions containing at least one heterobicyclic compound and/or pharmaceutically acceptable salts thereof. Furthermore, reaction procedures for the synthesis of the heterobicyclic compound are disclosed.

    专利号:US-6407103-B2
    优先权日:1998-04-21
    标 题:Indeno [1,2-c] pyrazol-4-ones and their uses
    发明人:NUGIEL DAVID A; CARINI DAVID J; DI MEO SUSAN V; YUE EDDY W
    权利人:BRISTOL MYERS SQUIBB PHARMA CO
    摘要:The present invention relates to the synthesis of a new class of indeno[1,2-c]pyrazol-4-ones of formula (I):that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-9 and their regulatory subunits know as cyclins A-H.This invention also provides a novel method of treating cancer or other proliferative diseases by administering a therapeutically effective amount of one of these compounds or a pharmaceutically acceptable salt form thereof. Alternatively, one can treat cancer or other proliferative diseases by administering a therapeutically effective combination of one of the compounds of the present invention and one or more other known anti-cancer or anti-proliferative agents.

    专利号:US-6011152-A
    优先权日:1996-07-22
    标 题 :Synthesis of macrocyclic tetraamido-N ligands

    专利号:US-7094909-B2
    优先权日:2001-06-11
    标 题 :HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
    发明人:KUCERA DAVID JOHN; SCOTT ROBERT WILLIAM
    权利人:AGOURON PHARMA
    摘要:The present invention concerns processes for preparing compounds of formula (I-H), or a prodrug, pharmaceutically active metabolite, or pharmaceutically active salt or solvate thereof, n nwhich are useful as inhibitors of the HIV protease enzyme.

    专利号:US-6166003-A
    优先权日:1999-02-17
    标 题 :Heterocyclic compounds for cancer chemoprevention
    发明人:LAM LUKE K T
    权利人:LKT LAB INC
    摘要:A compound comprising a heterocyclic moiety, such as a thiophene, covalently attached to an alkylene isothiocyanate moiety. The compound is effective to prevent the occurrence or progression of cancer or a precancerous condition, and can be used for therapeutic or prophylactic purposes. The compound can be provided and administered in the form of a pharmaceutical composition, a cosmetic, a food additive, supplement, or the like. Methods for synthesis and use of the chemopreventive compound of the invention are also provided.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Katrin Schweitzer, Et Al. P97/vcp Promotes Cullin-Ring-Ubiquitin-Ligase/proteasome-Dependent Degradation Of Iκbα And The Preceding Liberation Of Rela From Ubiquitinated Iκbα. J Cell Mol Med. 2016 Jan;20(1):58-70.

    合成参考文献


    参考文献:10.1186/1756-0500-7-357
    摘要:Wouters E, Hudson CA, McArdle CA, López Bernal A. Central role for protein kinase C in oxytocin and epidermal growth factor stimulated cyclooxygenase 2 expression in human myometrial cells. BMC Research Notes. 2014 Jun 10;7(1):357. doi: 10.1186/1756-0500-7-357.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知